No Picture
News

Inhibrx To Host Webcast Presentation of Topline Results from the Phase 1 Trial of INBRX-101, its Optimized Recombinant Human AAT-Fc Protein for the Treatment of Alpha-1 Antitrypsin Deficiency

Event to be webcast live on Monday, May 16, 2022 at 1:30 p.m. PT SAN DIEGO , May 12, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development […]

No Picture
News

Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and operating results for the first quarter […]

No Picture
News

Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the […]

No Picture
News

Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress

SAN DIEGO, Calif., SUZHOU and SHANGHAI, China , May 12, 2022 /PRNewswire/ — Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell […]

No Picture
News

Pipeline Therapeutics to Present at Multiple Investor Conferences in May 2022

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that company management will present at the following investor conferences: 2022 RBC Capital Markets Global Healthcare Conference Wednesday, May 18, 2022 at […]

No Picture
News

Amicrobe Selects Clinical Formulation for Amicidin-? PFC, Supported by Department of Defense for Prolonged Field Care of Injured Warfighters

Backed by a $3.99M Department of Defense award, issued August 2021 through MTEC, Amicidin-? PFC is intended to prevent life-threatening infections in military field settings CARLSBAD, Calif., May 10, 2022 /PRNewswire/ — Amicrobe, Inc. develops […]

No Picture
News

THE VETS LAUNCH 4 CITIES IN 45 DAYS

Mobile veterinarian care expands its services into Charlotte, Sacramento, Phoenix, and San Diego CHARLOTTE, N.C., May 10, 2022 /PRNewswire/ — The Vets, a mobile veterinary service providing premium at-home pet care, announces its expansion into […]

No Picture
News

Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®

SAN DIEGO, May 10, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has selected Bora Pharmaceuticals Services Inc. (Bora) Canada as Evofem’s new contract manufacturing organization (CMO). Bora will eventually manufacture Phexxi® […]

No Picture
News

Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction

SAN DIEGO–(BUSINESS WIRE)–Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction. “Despite the demonstrated […]

No Picture
News

Recordati Rare Diseases Announces Multiple Scientific Abstracts to Be Highlighted at American Association of Clinical Endocrinology

LEBANON, N.J.–(BUSINESS WIRE)–Recordati Rare Diseases Inc. announced today that various scientific abstracts have been accepted and will be featured onsite at the American Association of Clinical Endocrinology (AACE) annual meeting being held in San Diego, […]

No Picture
News

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine

SAN DIEGO, May 9, 2022 /PRNewswire/ — Hitachi High-Tech Corporation (“Hitachi High-Tech”) has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. (“Invivoscribe”), a global provider of blood cancer testing kits and services, by […]

No Picture
News

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners

Will Fund Clinical Trials of Company’s First iPSC-derived Autologous Dopamine Neuron Replacement for Parkinson’s Disease SAN DIEGO, May 9, 2022 /PRNewswire/ — Aspen Neuroscience, Inc., a private biotechnology company developing autologous cell therapies, including the […]

No Picture
News

Exclusive: Aspen Neuroscience collects large Series B to compete against Bayer’s Parkinson’s cell therapy

Damien McDevitt thinks frequently about the name Aspen Neuroscience. Specifically, should the neuroscience portion be dropped as the San Diego biotech considers expanding beyond the CNS? McDevitt, the 21-year GlaxoSmithKline veteran and former Akcea Therapeutics […]

No Picture
News

Equillium Announces Three Poster Presentations at the Annual Meeting of The American Association of Immunologists

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that three posters were […]